Diffussion Pharma Inc. (NASDAQ:DFFN) Stock Attempts To Rebound: How to Trade Now?
Diffussion Pharma Inc. (NASDAQ:DFFN) jumped 4.5% on no company-specific news or release. Recently, the company released a topline result for the phase 1 study of its flagship product, trans sodium crocetinate (TSC). The company used transcutaneous oxygen monitoring hg in the trial to assess direct TSC pharmacodynamics effects on peripheral oxygenation of tissue in healthy individuals. The topline findings were based on primary endpoint data analysis which showed a promising…